{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:14Z","timestamp":1790746754563,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/pai.0000000000000000","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T13:22:12Z","timestamp":1401888132000},"page":"663-668","source":"Crossref","is-referenced-by-count":19,"title":["Myelofibrotic Transformations of Polycythemia Vera and Essential Thrombocythemia are Morphologically, Biologically, and Prognostically Indistinguishable From Primary Myelofibrosis"],"prefix":"10.1097","volume":"22","author":[{"given":"Nikhil","family":"Sangle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin J.","family":"Teman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000101708","article-title":"Myelofibrosis--whats in a name Consensus on definition and EUMNET grading.","volume":"74","author":"Thiele","year":"2007","journal-title":"Pathobiology"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.leukres.2010.01.005","article-title":". Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study.","volume":"34","author":"Teman","year":"2010","journal-title":"Leuk Res"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2559.2010.03545.x","article-title":". Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.","volume":"56","author":"Brousseau","year":"2010","journal-title":"Histopathology"},{"key":"R5-6-20210126","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":". Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.","volume":"29","author":"Barbui","year":"2011","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"R6-6-20210126","first-page":"1128","article-title":". European consensus on grading bone marrow fibrosis and assessment of cellularity.","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"R7-6-20210126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.leu.2404914","article-title":". Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.","volume":"22","author":"Barosi","year":"2008","journal-title":"Leukemia"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":". Polycythemia vera is not initiated by JAK2V617F mutation.","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.172384399","article-title":". Prospective isolation of human clonogenic common myeloid progenitors.","volume":"99","author":"Manz","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/leu.2010.148","article-title":". A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.","volume":"24","author":"Passamonti","year":"2010","journal-title":"Leukemia"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.leukres.2010.06.017","article-title":". JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.","volume":"35","author":"Silver","year":"2010","journal-title":"Leuk Res"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/leu.2008.229","article-title":"JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.","volume":"22","author":"Kilpivaara","year":"2008","journal-title":"Leukemia"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bcmd.2007.01.003","article-title":". The expression of CXCR4 is down-regulated on the CD34 cells of patients with myelofibrosis with myeloid metaplasia.","volume":"38","author":"Rosti","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.thj.6200368","article-title":"Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.","volume":"5","author":"Michiels","year":"2004","journal-title":"Hematol J"}],"container-title":["Applied Immunohistochemistry & Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000000000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:29:42Z","timestamp":1620966582000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201410000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000000","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}